Sign in
4

Changes in Ownership

MYRIAD GENETICS INC Filed Acc 0001628280-25-013145

Chief Commercial Officer gave up 9,576 shares (to pay taxes)

  • Chief Commercial Officer acquired 99,227 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Verratti Mark Chief Commercial Officer 2025-03-13 Grant or award +99,227 401,262 D
Verratti Mark Chief Commercial Officer 2025-03-14 Shares withheld for taxes −5,847 $10.07 $58,879 395,415 D
Verratti Mark Chief Commercial Officer 2025-03-15 Shares withheld for taxes −3,729 $10.07 $37,551 391,686 D
Loading xslF345X05/wk-form4_1742242769.xml…